Similar to the observed effects in murine corticotroph tumor cells, MEK-162 treatment resulted in a ~60% reduction in cell proliferation (Figure 2D), ~40% decrease in POMC mRNA (Figure 2E) and ~70% decrease in ACTH secretion at 40 μM (Figure 2F). Here, POMC is linked to neoplasm.